Proteomic Analysis of COVID-19 Plasma Reveals Dysregulated TREM-1, I-17, and Tumor Microenvironment Pathways Associated with Disease Severity
Christopher V. Cosgriff(University of Pennsylvania), Nicole Meyer(Hospital of the University of Pennsylvania), C.A.G. Ittner(University of Pennsylvania), Ariel R. Weisman(University of Pennsylvania), R.S. Agyekum(Translational Therapeutics (United States)), Divij Mathew(Parker Institute for Cancer Immunotherapy), Brian J. Anderson(University of Pennsylvania), Tiffanie K. Jones(University of Pennsylvania), E. John Wherry(Parker Institute for Cancer Immunotherapy), M. Betina Pampena(University of Pennsylvania), H.M. Giannini(Lung Institute), Amy E. Baxter(Translational Therapeutics (United States)), Leticia Kuri-Cervantes(University of Pennsylvania), Kurt D’Andrea(University of Pennsylvania), John P. Reilly(University of Pennsylvania), M.G.S. Shashaty(University of Pennsylvania), Thomas Dunn(Translational Therapeutics (United States)), Michael R. Betts(University of Pennsylvania)
Cited by 0
Related Papers
Lineage relationship and protective immunity of memory CD8 T cell subsets
|Nature Immunology|2003|1.9k
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
|Nature|2010|1.8k
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
|Journal of Immunological Methods|2003|1.6k
HIV preferentially infects HIV-specific CD4+ T cells
|Nature|2002|1.3k